Managing test utilization reveals opportunities for improved laboratory performance and better patient care
The laboratory reimbursement market is shifting away from consumption-, fee-for-service-, and transaction-based paradigms to models based on the quality and value of the services provided by clinical labs. Payors are increasingly asking health systems and their providers to respond by providing high-quality care while being mindful of financial performance.
In turn, the move away from fee-for-service payments in favor of other models of reimbursement—especially bundled payment models—is causing lab managers to take a hard look at how they can reduce unnecessary testing.
Read more: Data Analytics in the Clinical Laboratory
Source: clpmag
